Cover
Cover - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Mar. 21, 2022 | Jun. 30, 2021 | |
Document Information [Line Items] | |||
Document Type | 10-K/A | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2021 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Transition Report | false | ||
Entity File Number | 001-04321 | ||
Entity Registrant Name | CENTESSA PHARMACEUTICALS PLC | ||
Entity Incorporation, State or Country Code | X0 | ||
Entity Tax Identification Number | 98-1612294 | ||
Entity Address, Address Line One | 3rd Floor | ||
Entity Address, Address Line Two | 1 Ashley Road | ||
Entity Address, Address Line Three | Altrincham | ||
Entity Address, City or Town | Cheshire | ||
Entity Address, Postal Zip Code | WA14 2DT | ||
Entity Address, Country | GB | ||
Country Region | +44 | ||
City Area Code | 203 | ||
Local Phone Number | 9206789 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 1,073,339,335 | ||
Entity Common Stock, Shares Outstanding | 94,020,005 | ||
Documents Incorporated by Reference | . | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0001847903 | ||
Common Stock | |||
Document Information [Line Items] | |||
Title of 12(b) Security | Ordinary shares, nominal value £0.002 per share | ||
Trading Symbol | CNTA | ||
Security Exchange Name | NASDAQ | ||
American Depositary Shares | |||
Document Information [Line Items] | |||
Title of 12(b) Security | American Depositary Shares (“ADSs”), each representing one ordinary share, nominal value £0.002 per share | ||
Trading Symbol | CNTA | ||
Security Exchange Name | NASDAQ |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2021 | |
Audit Information [Abstract] | |
Auditor Name | KPMG LLP |
Auditor Location | Boston, MA |
Auditor Firm ID | 185 |